Skip to content
6-K

Foreign Interim / Material

Akso Health Group AHG

0001213900-24-000418

← back to feed
Filed
Jan 3, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Short Term Debt Q2 2024 · Sep 30, 2023 $350K
Cash And Equivalents Q2 2024 · Sep 30, 2023 $9.21M
Cash And Equivalents Q2 2024 · Mar 31, 2023 $7.92M
Stockholders Equity Q2 2024 · Sep 30, 2023 $5.22M
Stockholders Equity Q2 2024 · Mar 31, 2023 $8.73M
Current Liabilities Q2 2024 · Sep 30, 2023 $11.55M
Current Liabilities Q2 2024 · Mar 31, 2023 $11.62M
Total Liabilities Q2 2024 · Sep 30, 2023 $11.55M
Total Liabilities Q2 2024 · Mar 31, 2023 $11.62M
Current Assets Q2 2024 · Sep 30, 2023 $16.88M
Current Assets Q2 2024 · Mar 31, 2023 $20.46M
Total Assets Q2 2024 · Sep 30, 2023 $16.88M
Total Assets Q2 2024 · Mar 31, 2023 $20.46M
Shares Diluted Q2 2024 · Sep 30, 2022 68.6M sh
Operating Cash Flow Q2 2024 · Sep 30, 2022 −$1.33M
Eps Diluted Q2 2024 · Sep 30, 2022 $0.01
Eps Basic Q2 2024 · Sep 30, 2022 $0.01
Net Income Q2 2024 · Sep 30, 2022 $810.34K
Operating Income restated Q2 2024 · Sep 30, 2022 −$220.16K
Gross Profit restated Q2 2024 · Sep 30, 2022 $1.13M